Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2024-12-30 00:00:00 ET · period of report 2024-12-27 · accession 0001104659-24-132582 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-30 | 2024-12-27 | OBIO | Aryeh Jason | Dir | M - OptEx | $4.30 | +11.7K | 80.1K | +17% | +$50.3K |
| D | 2024-12-30 | 2024-12-27 | OBIO | Aryeh Jason | Dir | M - OptEx | $0.00 | -11.7K | 6,900 | -63% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share ("Common Stock") | 2024-12-27 | M | A | 11,700 | $4.30 | 80,060 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-12-27 | M | D | 11,700 | $0.00 | 6,900 | D | $4.30 · 2023-01-26 to 2028-11-16 | 11,700 Common Stock |